User profiles for Camillo Rossi
 | Camillo Rossi, MD, PhD, MPHDirettore Medico ASST Franciacorta Verified email at asst-franciacorta.it Cited by 7081 |
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
INTRODUCTION Interindividual clinical variability is vast in humans infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
INTRODUCTION Clinical outcomes of human severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection range from silent infection to lethal coronavirus disease 2019 (…
2 (SARS-CoV-2) infection range from silent infection to lethal coronavirus disease 2019 (…
[HTML][HTML] An immune-based biomarker signature is associated with mortality in COVID-19 patients
…, A Sottini, E Quiros-Roldan, F Castelli, C Rossi… - JCI insight, 2021 - ncbi.nlm.nih.gov
Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
contribute to disease severity of coronavirus disease 2019 (COVID-19). …
contribute to disease severity of coronavirus disease 2019 (COVID-19). …
[PDF][PDF] Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
COVID-19 exhibits extensive patient-to-patient heterogeneity. To link immune response
variation to disease severity and outcome over time, we longitudinally assessed circulating …
variation to disease severity and outcome over time, we longitudinally assessed circulating …
[HTML][HTML] Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels
…, S Barrio, L Imberti, A Sottini, E Quiros-Roldan, C Rossi… - MedRxiv, 2020 - ncbi.nlm.nih.gov
T cells are involved in the early identification and clearance of viral infections and also
support the development of antibodies by B cells. This central role for T cells makes them a …
support the development of antibodies by B cells. This central role for T cells makes them a …
Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study
…, A Zambon, L Bertu, A Mauri, V Paleari, C Rossi… - Drug safety, 2006 - Springer
Objective: To investigate the association between the use of fluoroquinolone agents and the
risk of tendinitis in a large population-based case-control study. Methods: The study was …
risk of tendinitis in a large population-based case-control study. Methods: The study was …
[HTML][HTML] Autoantibodies against proteins previously associated with autoimmunity in adult and pediatric patients with COVID-19 and children with MIS-C
The antibody profile against autoantigens previously associated with autoimmune diseases
and other human proteins in patients with COVID-19 or multisystem inflammatory syndrome …
and other human proteins in patients with COVID-19 or multisystem inflammatory syndrome …
[HTML][HTML] Immune responses to SARS-CoV-2 infection and vaccine in a big Italian COVID-19 hospital: An 18-month follow-up
…, MM Tiraboschi, T Pedrazzi, M Lombardo, C Rossi… - Vaccines, 2022 - mdpi.com
Objectives: This is a longitudinal prospective study which was designed to assess the trend
of anti-SARS-CoV-2 antibodies targeting the Spike (anti-S) and Nucleocapside protein (anti-…
of anti-SARS-CoV-2 antibodies targeting the Spike (anti-S) and Nucleocapside protein (anti-…
[HTML][HTML] The impact of COVID-19 pandemic on AMI and stroke mortality in Lombardy: Evidence from the epicenter of the pandemic
Background The first Covid-19 epidemic outbreak has enormously impacted the delivery of
clinical healthcare and hospital management practices in most of the hospitals around the …
clinical healthcare and hospital management practices in most of the hospitals around the …
Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use
L Zanotti, A Bottini, C Rossi, D Generali, MR Cappelletti - Tumor Biology, 2014 - Springer
Breast cancer is a complex disease with heterogeneous presentation and clinical course.
The last decade has witnessed the development, commercialization, and increasing use of …
The last decade has witnessed the development, commercialization, and increasing use of …